Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07222085 · ClinicalTrials.gov registry record · NA
Long-Term Stability of the Glide Control Strategy
A NA study of Upper Limb Amputation Above Elbow and Upper Limb Amputation Below Elbow, sponsored by Infinite Biomedical Technologies.
- Recruiting
- Registry status
- NA
- Development phase
- 12
- Enrollment target
- 10
- Study locations
NCT07222085: Recruiting NA study of Upper Limb Amputation Above Elbow and Upper Limb Amputation Below Elbow, sponsored by Infinite Biomedical Technologies.
NCT07222085 is a NA study of Upper Limb Amputation Above Elbow and Upper Limb Amputation Below Elbow that is actively recruiting participants, run by Infinite Biomedical Technologies. The registered enrollment target is 12 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (99% lower). The trial reports 10 study locations across 5 states. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT07222085, a NA study of Upper Limb Amputation Above Elbow and Upper Limb Amputation Below Elbow, is actively recruiting participants, sponsored by Infinite Biomedical Technologies.
- RECRUITING
- Registry status
- NA
- Development phase
- 12 participants
- Enrollment target
- 10
- Study locations
Study Summary
This research is intended to test whether the prescription of the Glide prosthesis control system reduces the burden of use for both patients and their clinical care team as compared to use of Pattern Recognition-based advanced myoelectric control. The goal of the study is to fill the gaps in clinically relevant knowledge to inform the prescription of prosthesis components and the rehabilitation process.
Primary Outcome
DMNCAS quantifies the number of times a prosthesis user needs to adjust their control strategy to maintain performance. For a PR system, a control adjustment refers to a calibration (or recalibration) of one or more prosthesis movements, while for the Glide control strategy, a control adjustment refers to a change in the Glide map configuration (e.g., electrode gains, slice geometries, assigned movements, etc.). A control adjustment session is then a period of time devoted to performing one or m
Conditions Studied
Interventions
- DEVICE Glide Control System
- DEVICE Pattern Recognition System
Study Locations (10)
Maryland
- Medical Center Orthotics and Prosthetics - Annapolis - Annapolis
- Medical Center Orthotics and Prosthetics - Baltimore - Baltimore
- Medical Center Orthotics and Prosthetics - Silver Spring - Silver Spring
Massachusetts
- Medical Center Orthotics and Prosthetics - Allston - Allston
- Medical Center Orthotics and Prosthetics - Milton - Milton
South Carolina
- Medical Center Orthotics and Prosthetics - Anderson - Anderson
- Medical Center Orthotics and Prosthetics - Greenville - Greenville
Virginia
- Medical Center Orthotics and Prosthetics - Fairfax - Fairfax
- Medical Center Orthotics and Prosthetics - Leesburg - Leesburg
North Carolina
- Medical Center Orthotics and Prosthetics - Charlotte - Charlotte
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 12 participants |
| Start Date | 2025-10-15 |
| Est. Completion | 2029-04 |
| Phase | NA |
What NCT07222085 shows while recruiting
NCT07222085 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 12 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (99% lower).
The record links to 2 conditions, with Upper Limb Amputation Above Elbow appearing as the primary indexed condition, and to 2 interventions - of which Glide Control System is the first listed.
NCT07222085 lists 10 locations in 5 states (Maryland, Massachusetts, South Carolina).
Frequently Asked Questions
What is clinical trial NCT07222085 about?
NCT07222085 is a clinical study titled "Long-Term Stability of the Glide Control Strategy". This research is intended to test whether the prescription of the Glide prosthesis control system reduces the burden of use for both patients and their clinical care team as compared to use of Pattern Recognition-based advanced myoelectric control. The goal of the study is to fill the gaps in clinic...
What is the current status of trial NCT07222085?
This trial is currently recruiting. It is a NA study. The enrollment target is 12 participants. The study started on 2025-10-15. Estimated completion is 2029-04.
What conditions does trial NCT07222085 study?
This clinical trial studies the following conditions: Upper Limb Amputation Above Elbow, Upper Limb Amputation Below Elbow.
What interventions are being tested in trial NCT07222085?
The interventions under investigation include: Glide Control System (DEVICE), Pattern Recognition System (DEVICE).
Who is sponsoring clinical trial NCT07222085?
This trial is sponsored by Infinite Biomedical Technologies, which has 4 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT07222085 being conducted?
This trial has 10 study locations across Maryland, Massachusetts, North Carolina, South Carolina, Virginia. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT07222085's enrollment target sits among peer trials
12 1913th of 2000 higher than 74 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02602769 · 12 participants
Whole Transcriptome Profiling and Metabolic Phenotyping in Children With ROHHAD Syndrome
- NCT02605421 · 12 participants · Phase 2
Myeloablative Consolidation Therapy and Tandem Autologous Stem Cell Rescue in Patients With High-Risk Neuroblastoma
- NCT02619448 · 12 participants · Early Phase 1
Concurrent Chemotherapy Plus HFR Radiation Therapy in Inoperable NSCLC
- NCT03311503 · 12 participants · Phase 1
Phase I/II Trial of Lentiviral Gene Transfer for SCID-X1 With Low Dose Targeted Busulfan Conditioning
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI